Insider Selling: MedEquities Realty Trust Inc (MRT) Director Sells 25,000 Shares of Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $8.39, for a total value of $209,750.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Wednesday, October 31st, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total value of $84,500.00.
  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total value of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total value of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.65, for a total value of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.54, for a total value of $42,700.00.
  • On Wednesday, October 17th, Bluemountain Capital Managemen sold 23,200 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.84, for a total value of $205,088.00.
  • On Friday, October 12th, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.74, for a total value of $87,400.00.
  • On Monday, October 15th, Bluemountain Capital Managemen sold 21,289 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.80, for a total value of $187,343.20.
  • On Wednesday, October 10th, Bluemountain Capital Managemen sold 12,816 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $9.16, for a total value of $117,394.56.
  • On Friday, October 5th, Bluemountain Capital Managemen sold 3,955 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $9.13, for a total value of $36,109.15.

Shares of NYSE MRT opened at $8.49 on Wednesday. The firm has a market capitalization of $271.47 million, a PE ratio of 7.45 and a beta of 0.65. MedEquities Realty Trust Inc has a 12-month low of $8.25 and a 12-month high of $12.04.

MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings data on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.20). The company had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. Analysts anticipate that MedEquities Realty Trust Inc will post 1.08 EPS for the current year.

MRT has been the topic of a number of research reports. ValuEngine upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Tuesday, July 10th. Zacks Investment Research upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating and set a $13.00 price target on the stock in a research note on Wednesday, July 25th. KeyCorp cut MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 price target on the stock. in a research note on Wednesday, August 8th. Canaccord Genuity decreased their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, August 9th. Finally, B. Riley set a $12.00 price target on MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Thursday, August 9th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company’s stock. MedEquities Realty Trust currently has an average rating of “Hold” and an average price target of $11.25.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd acquired a new stake in shares of MedEquities Realty Trust in the second quarter valued at $198,000. Putnam Investments LLC acquired a new stake in shares of MedEquities Realty Trust in the second quarter valued at $257,000. BlackRock Inc. raised its stake in shares of MedEquities Realty Trust by 5.5% in the second quarter. BlackRock Inc. now owns 1,499,494 shares of the financial services provider’s stock valued at $16,526,000 after acquiring an additional 77,884 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of MedEquities Realty Trust by 221.9% in the first quarter. JPMorgan Chase & Co. now owns 19,898 shares of the financial services provider’s stock valued at $210,000 after acquiring an additional 13,717 shares in the last quarter. Finally, Martingale Asset Management L P increased its holdings in MedEquities Realty Trust by 2.0% in the second quarter. Martingale Asset Management L P now owns 258,242 shares of the financial services provider’s stock valued at $2,846,000 after buying an additional 5,100 shares during the last quarter. Institutional investors and hedge funds own 91.02% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/11/07/insider-selling-medequities-realty-trust-inc-mrt-director-sells-25000-shares-of-stock.html.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

See Also: Fiduciary

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply